Aller au contenu principal
Profil bibliographique

Federica Frezzato

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

124Publications signalées
1857Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentImmunodeficiency and Autoimmune DisordersPhagocytosis and Immune RegulationGalectins and Cancer Biology

Les publications récentes

Accès ouvert 2026 article OpenAlex

Focal adhesion kinase FAK interplays with ROR1 in the aggressiveness of chronic lymphocytic leukemia

Maria Castronuovo, Guido Capasso, Allison Beltrame, Nayla Mouawad et autres

BACKGROUND: In chronic lymphocytic leukemia (CLL), B-cell receptor, chemokine receptor and integrin signaling contribute to disease progression by influencing cell survival, migration and microenvironment interactions. Focal adhesion kinase (FAK) has recently been involved in these disease processes. Our recent research revealed a …

it (code pays fourni par la source)

0 citations BMC Medicine
Accès ouvert 2026 review OpenAlex

Outcomes of patients with CLL and borderline IGHV mutational status: a systematic review and meta analysis

Francesco Angotzi, Arianna Bevilacqua, Andrea Serafin, Nicolò Danesin et autres

The immunoglobulin heavy chain variable region (IGHV) mutational status is a major prognostic factor in chronic lymphocytic leukemia (CLL). While patients are conventionally classified as mutated (M-IGHV) or unmutated (U-IGHV) using a 98% germline identity cutoff, increasing interest has focused on patients …

it (code pays fourni par la source)

1 citation Biomarker Research
Accès ouvert 2025 article OpenAlex

Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

Andrea Visentin, Enrico Gaffo, Moritz Fürstenau, Kerry A. Rogers et autres

In chronic lymphocytic leukemia (CLL), the role of complex karyotype (CK) for prognostic stratification remains a topic of debate, and the impact of specific cytogenetic abnormalities is still unclear. This study aims to investigate the clinical and biological features of CLL with …

it, de, us, se, cn, cz, gb, fr, gr, es, nl, ru (code pays fourni par la source)

2 citations Leukemia
Accès ouvert 2025 article OpenAlex

Interplay Between Protein Phosphatase 2A (PP2A) and SE Translocation (SET) as Macromolecular Target of Anticancer Compounds: A Combined Computational and Experimental Study

Giovanni Ribaudo, Mario A. Pagano, Margrate Anyanwu, Matteo Giannangeli et autres

Cancer represents a leading cause of mortality globally, with its complex biological nature posing significant challenges for treatment. Central to cancer progression are molecular pathways that govern cellular function, among which protein phosphatase 2A (PP2A) plays a vital role. As a serine/threonine …

it (code pays fourni par la source)

0 citations Macromol—A Journal of Macromolecular Research
Accès ouvert 2025 article OpenAlex

Serum soluble interleukin‐2 receptor levels in hairy cell leukaemia as a marker of tumour burden with prognostic value and as a tool for disease monitoring

Francesco Angotzi, Alessandro Cellini, Nicolò Danesin, Simone Zoletto et autres

Leukaemic cells from hairy cell leukaemia (HCL) secrete a soluble form of the interleukin-2 receptor (sIL-2R) which is measurable in serum. Previous evidence suggested that sIL-2R may correlate well with tumour burden and demonstrated a reduction in sIL-2R levels after therapy with …

it (code pays fourni par la source)

2 citations British Journal of Haematology
Accès ouvert 2025 article OpenAlex

Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study

Eleonora Roncaglia, Enrico Gaffo, Giulia Calabretto, Moritz Fürstenau et autres

In Chronic Lymphocytic Leukemia (CLL), t(14;19)(q32;q13), leading to the overexpression of BCL3, is found in ∼1% of cases and is associated with an aggressive disease. In this study, leveraging a large CLL patient cohort collected thanks to an international collaboration, we investigate …

it, de, us, se, cn, cz, gb, fr, gr, es, nl, ru (code pays fourni par la source)

1 citation Journal of Hematology & Oncology
Accès ouvert 2024 article OpenAlex

Focal adhesion kinase as a new player in the biology of onco-hematological diseases: the starting evidence

Guido Capasso, Nayla Mouawad, Maria Castronuovo, Edoardo Ruggeri et autres

Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase mainly found in the focal adhesion regions of the plasma membrane and it has a crucial role in migration and the remodeling of cellular morphology. FAK is also linked to several aspects of …

it (code pays fourni par la source)

1 citation Frontiers in Oncology
Accès ouvert 2024 article OpenAlex

Protein kinase CK2α is overexpressed in classical hodgkin lymphoma, regulates key signaling pathways, PD-L1 and may represent a new target for therapy

Edoardo Ruggeri, Federica Frezzato, Nayla Mouawad, Marco Pizzi et autres

Introduction: In classical Hodgkin lymphoma (cHL), the survival of neoplastic cells is mediated by the activation of NF-κB, JAK/STAT and PI3K/Akt signaling pathways. CK2 is a highly conserved serine/threonine kinase, consisting of two catalytic (α) and two regulatory (β) subunits, which is …

it (code pays fourni par la source)

7 citations Frontiers in Immunology
Accès ouvert 2024 article OpenAlex

Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax‐based regimens

Andrea Serafin, Alessandro Cellini, Chiara Adele Cavarretta, Valeria Ruocco et autres

Although the unfavourable prognostic role of complex karyotype (CK) in chronic lymphocytic leukaemia (CLL) patients treated with chemoimmunotherapy has been clarified, its impact on the outcome of patients being treated with novel targeted agents, and especially with venetoclax-based regimens, remains to be …

it (code pays fourni par la source)

7 citations British Journal of Haematology
Accès ouvert 2024 article OpenAlex

Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course

Francesco Angotzi, Alessandro Cellini, Valeria Ruocco, Chiara Adele Cavarretta et autres

Chronic lymphocytic leukemia (CLL) exhibits substantial variability in disease course. The mutational status of the B-cell receptor immunoglobulin heavy variable (IGHV) chain is a critical prognostic factor, categorizing patients into mutated (M-IGHV) and unmutated (U-IGHV) groups. Recently, a third subgroup with borderline …

it (code pays fourni par la source)

6 citations Cancers

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.